132
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors

ORCID Icon, , , , , & ORCID Icon show all
Pages 3637-3648 | Published online: 30 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Robert Arnold & Mario Angi. (2022) Multifaceted Amblyopia Screening with blinq, 2WIN, and PDI Check. Clinical Ophthalmology 16, pages 411-421.
Read now
Robert Arnold, David Silbert & Heather Modjesky. (2022) Instrument Referral Criteria for PlusoptiX, SPOT and 2WIN Targeting 2021 AAPOS Guidelines. Clinical Ophthalmology 16, pages 489-505.
Read now

Articles from other publishers (1)

Robert W Arnold. (2022) Comparative Validation of PlusoptiX and AI-Optic Photoscreeners in Children with High Amblyopia Risk Factor Prevalence. Clinical Ophthalmology Volume 16, pages 2639-2650.
Crossref